Table 3

Independent Predictors of IPST

VariableAdjusted Odds Ratio
(95% CI)
p Value
STEMI (vs. SA)1.87 (1.04–3.36)0.04
NSTE-ACS (vs. SA)2.07 (1.26–3.40)0.004
Thrombus at baseline1.79 (1.12–2.84)0.01
Total stent length (per 1-mm increase)1.03 (1.02–1.03)<0.0001
Cangrelor at randomization (vs. clopidogrel)0.65 (0.42–1.00)0.048

*Candidate variables included in the model: current smoker, diagnosis at presentation (stable angina vs. NSTE-ACS vs. STEMI), number of PCI vessels, DES versus BMS used, total stent length, TIMI flow at baseline (3 vs. 0-1-2), presence of thrombus at baseline, U.S. versus non-U.S. site, cangrelor infusion.

BMS = bare-metal stent(s); DES = drug-eluting stent(s); SA = stable angina; other abbreviations as in Tables 1 and 2.